Literature DB >> 7517213

Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients.

H Nakakuma1, S Nagakura, K Horikawa, M Hidaka, T Kawaguchi, N Iwamoto, I Sanada, T Kagimoto, K Takatsuki.   

Abstract

Peripheral blood T lymphocytes obtained from two patients with paroxysmal nocturnal hemoglobinuria (PNH) were immortalized with human T-lymphotropic virus type 1 (HTLV-1). These cells showed interleukin-2 (IL-2)-dependent cell growth in culture. Cell surface analysis showed that they had the phenotype of a helper/inducer T subset that was positive for CD2, CD3, and CD4, but negative for CD8, similar to adult T-cell leukemia cells induced by HTLV-1. These cell lines lacked glycosylphosphatidylinositol (GPI)-anchored proteins, CDw52, CD55 (decay-accelerating factor; DAF), and CD59 on the cell surface, whereas intracellular DAF protein was detected. These T-subset cell lines with a PNH phenotype did not synthesize GPI anchor, whereas a control cell line, similarly prepared from the T cells of a healthy volunteer, produced the anchor. The control cells expressed CDw52, DAF, and CD59 on the cell surface and showed the phenotype of a helper/inducer subset. Southern blot analysis confirmed the clonality of each cell line. These CD4+ T-cell lines with a PNH phenotype and a subset-matched control counterpart could be a useful model for PNH investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517213

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2.

Authors:  S L Tarsis; M T Yu; E S Parks; D Persaud; J L Muñoz; W P Parks
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

2.  Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Pusem Patir; Yakup Isik; Yigit Turk; Mehmet Can Ugur; Cengiz Ceylan; Gulnur Gorgun; Nihal Mete Gokmen; Guray Saydam; Fahri Sahin
Journal:  Case Rep Hematol       Date:  2015-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.